REXULTI (Avera McKennan Hospital)
Welcome to the PulseAid listing for the REXULTI drug offered from Avera McKennan Hospital. This Atypical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
| NON-PROPRIETARY NAME: | brexpiprazole |
| SUBSTANCE NAME: | BREXPIPRAZOLE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Atypical Antipsychotic [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-06-17 |
| END MARKETING DATE: | 0000-00-00 |
REXULTI HUMAN PRESCRIPTION DRUG Details:
| Item Description | REXULTI from Avera McKennan Hospital |
| LABELER NAME: | Avera McKennan Hospital |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/1) |
| START MARKETING DATE: | 2016-06-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69189-0642_0213378c-31e8-4199-a160-5bfe7b49389a |
| PRODUCT NDC: | 69189-0642 |
| APPLICATION NUMBER: | NDA205422 |
Other BREXPIPRAZOLE Pharmaceutical Manufacturers / Labelers:
